ISMETT, in Italian, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione translated as the Mediterranean Institute for Transplantation and Advanced Specialized Therapies, is a center for organ transplantation located in Palermo, Italy.

There are 70 beds in ISMETT.

During the past decade, ISMETT conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ISMETT" #1 sponsor was "The Mediterranean Institute for Transplantation and Advanced Specialized Therapies" with 6 trials, followed by "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Astellas Pharma Europe Ltd." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ISMETT" #1 collaborator was "Istituto Di Ricerche Farmacologiche Mario Negri" with 2 trials as a collaborator, "AISF (Associazione Italiana per lo Studio del Fegato)" with 1 trials as a collaborator, "ASST-Sette Laghi Università degli Studi dell'Insubria Varese" with 1 trials as a collaborator, "Associazione Italiana per la Ricerca sul Cancro" with 1 trials as a collaborator and "Azienda Policlinico Umberto I" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "ISMETT" are "Pulmonary Arterial Hypertension" (4 trials), "Liver Transplantation" (2 trials), "Abdominal Neoplasms" (1 trials), "Anticoagulant-induced Bleeding" (1 trials) and "Aortic Stenosis" (1 trials). Many other conditions were trialed in "ISMETT" in a lesser frequency.

Most popular intervention types in "ISMETT" are "Drug" (10 trials), "Other" (5 trials), "Device" (4 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Albumin" (1 trials), "Application of a prognostic score" (1 trials), "Balanced" (1 trials) and "CUSA Clarity Ultrasonic Surgical Aspirator System use" (1 trials). Other intervention names were less common.

The vast majority of trials in "ISMETT" are 24 trials for "All" genders.

Currently, there are NaN active trials in "ISMETT". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in ISMETT, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in ISMETT, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

ISMETT has several departments that took part in Clinical trials: "Ismett Istituto Mediterraneo Trapianti E Terapie Alta Specializzazione;Pneumologia" - 4 trials